Injectable Opdivo 'Can Achieve the Same Goals' as IV Use in RCC

Subcutaneous administration of Opdivo, could increase efficiency and reduce wait times for patients, as one expert explains to CURE®.

Related Keywords

,Roswell Park ,Saby George ,Drug Administration ,Network Clinical Trials ,University Of Buffalo ,Biomedical Sciences ,Jacobs School Of Medicine ,Roswell Park Comprehensive Cancer Center ,Subcutaneous Opdivo ,Jacobs School ,Subcutaneous Versus Intravenous ,Kidney Cancer ,Renal Cell Carcinoma ,Immunotherapy ,Opdivo ,Nivolumab ,